Drug Profile
Hyaluronidase - Karo Pharma
Alternative Names: BP 03; BP 05Latest Information Update: 03 Dec 2021
Price :
$50
*
At a glance
- Originator BioPhausia
- Class Antineoplastics; Glycoside hydrolases; Polysaccharide lyases
- Mechanism of Action Hyaluronic acid modulators; Hyaluronidase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Oedema
Most Recent Events
- 26 Jan 1999 New profile
- 26 Jan 1999 Preclinical development for Cancer in Sweden (Unknown route)
- 26 Jan 1999 Preclinical development for Oedema in Sweden (Unknown route)